- TRT
- $249 first month, then $149/month
- Enclomiphene ODT (compounded)
- From $129/month
- Sermorelin ODT (compounded)
- From $199/month
- NAD+ Injection (compounded)
- From $199/month
What andropause means, and what it doesn't
"Andropause" is a popular term for the gradual drop in testosterone many men experience with age. Unlike menopause, it is not a sudden or universal shift, and many older men keep normal levels. Low testosterone, when it occurs, is diagnosed by symptoms plus at least two low early-morning blood tests.
Many symptoms blamed on andropause, including fatigue, low mood, weight gain and lower libido, also come from poor sleep, sleep apnea, alcohol, depression, medications or excess body fat. That is why measurement comes before treatment.
Testosterone comes first
If labs confirm a deficiency and symptoms fit, testosterone therapy or an alternative is the foundation. Peptides do not raise testosterone in a meaningful, proven way, and they do not treat hypogonadism.
- Testosterone replacement ($249 first month, then $149/month): effective for symptoms of true deficiency, but it suppresses sperm production and needs monitoring of hematocrit, PSA and blood pressure.
- Enclomiphene / DHEA / Boron / Pregnenolone ODT (from $129/month, compounded): stimulates your own testosterone production and generally preserves sperm production. Enclomiphene is not FDA-approved, and the compounded product is not FDA-approved.
Where peptides may be considered
Once hormones are addressed, or if they turn out to be normal, some men want to explore recovery, sleep or energy. A clinician may discuss:
- Sermorelin (from $199/month): a growth hormone–releasing hormone analog. A sermorelin product was once FDA-approved and later discontinued for reasons the FDA found were unrelated to safety or effectiveness. Compounded sermorelin is not FDA-approved, and evidence in healthy midlife men is limited.
- NAD+ injection (from $199/month): explored for cellular energy, with early and mixed human evidence. Compounded NAD+ is not FDA-approved.
The midsection question
Peptides are not a proven fat-loss treatment. Abdominal fat in midlife responds to calorie balance, strength training, sleep and alcohol reduction. For men who meet the criteria, a GLP-1 medication may be considered. Treating low testosterone can help body composition in men who are truly deficient, and losing excess weight can itself raise testosterone.
An honest word on the evidence
Some peptides have been marketed well ahead of the research. FDA scientists who reviewed several popular peptides in 2026 found the human data insufficient to establish safety or effectiveness, and none of the wellness peptides offered here is FDA-approved. We may tell you a peptide is not worth it for you, and that is a legitimate outcome.
Safety when combining with testosterone therapy
- Tell your clinician about every product you use, including supplements and anything bought online.
- Growth hormone–related therapies are not appropriate with active cancer, including untreated prostate cancer.
- Men subject to sports drug testing should know that testosterone, many peptides and enclomiphene are prohibited.
- Keep up with scheduled hematocrit and PSA checks while on testosterone.
Sleep, alcohol and testosterone
Short or fragmented sleep lowers testosterone in men, and untreated obstructive sleep apnea is both common in midlife men and linked with low levels. Alcohol, especially regular heavy drinking, can also suppress testosterone and disrupt sleep. If you snore loudly or wake unrefreshed, ask about sleep apnea testing before assuming you need hormones or peptides; testosterone therapy can also worsen untreated sleep apnea.
How we approach it
You start with the free eligibility check, then baseline labs including morning testosterone, LH and FSH, blood counts and, for men over 40, PSA. Your clinician explains the results, recommends hormone treatment if indicated and discusses whether a peptide is worth a defined trial afterward.